SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 120 filers reported holding SYNAGEVA BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,981,000 | +176.3% | 32,122 | +104.8% | 0.12% | +192.7% |
| Q3 2014 | $1,079,000 | -68.0% | 15,686 | -51.3% | 0.04% | -62.4% |
| Q2 2014 | $3,374,000 | +66.7% | 32,198 | +32.0% | 0.11% | +70.3% |
| Q1 2014 | $2,024,000 | +27.4% | 24,392 | -2.7% | 0.06% | +4.9% |
| Q3 2013 | $1,589,000 | -74.5% | 25,060 | -83.1% | 0.06% | -77.6% |
| Q2 2013 | $6,233,000 | – | 148,411 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |